As of 2026-08-15, the Fair Value of Cogent Biosciences Inc (COGT) is -10.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 37.31 USD, the upside of Cogent Biosciences Inc is -127.79%.
With the market price of 37.31 USD and our fair value calculation, Cogent Biosciences Inc (COGT) is not a good investment. Investing in COGT stocks now will result in a potential loss of 127.79%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -74.81 | -72.27 | -140.24 | -192.41 | -256.00 | -147.15 |
| YoY growth | -135.03% | 3.40% | -94.05% | -37.20% | -33.05% | -59.19% |
| Market Cap (mil) | 6,375.16 |
| P/E | |
| Forward P/E |
| EPS | -2.07 |
| Avg earnings growth rate | -59.19% |
| TTM earnings | -354.30 |